Evidence map›Paper›PMID 42176416›Full record

ArticleJournal of Ayurveda and integrative medicine

Impact of tariff on Indian AYUSH products: Evidence from top importers of India.

Saravanan Sengunthar, Diganta Sarkar, Pravin Jadhav

Abstract read
In one paragraph

Article in Journal of Ayurveda and integrative medicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Saravanan SenguntharInstitute of Infrastructure, Technology, Research and Management (IITRAM), Ahmedabad 380026, Gujarat, India.
Diganta SarkarInstitute of Infrastructure, Technology, Research and Management (IITRAM), Ahmedabad 380026, Gujarat, India. Electronic address: digantasarkarofficial@gmail.com.
Pravin JadhavInstitute of Infrastructure, Technology, Research and Management (IITRAM), Ahmedabad 380026, Gujarat, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background The global demand for Indian AYUSH (Ayurveda, Yoga & Naturopathy, Unani, Siddha, and Homeopathy) products has been rising, yet the impact of tariff reduction on their trade remains largely unexplored. Objective This study aims to assess the effects of tariff reduction on AYUSH product exports to eight major importing countries, which collectively account for approximately 50% of India's AYUSH exports. Methods The analysis covers 19 eight-digit HS codes specified by AYUSHEXCIL, which include traditional AYUSH products along with related cosmetic and dental preparations that contain herbal and traditional medicine ingredients, as dedicated six-digit HS codes for pure AYUSH products are not available in the international trade classification system. Using secondary trade data, the research employs a Partial Equilibrium Analysis through the Trade Intelligence and Negotiation Advisor (TINA) model to simulate trade scenarios under reduced tariff conditions. Results The findings indicate that while tariff reductions generally enhance trade, a blanket zero-tariff policy across all AYUSH products is not advisable. In certain product categories, trade diversion outweighs trade creation, leading to potential welfare losses for India. Conclusion The study provides critical insights for policymakers, suggesting a selective tariff reduction strategy that maximizes trade benefits while safeguarding national economic interests.The findings underscore the importance of integrating product-specific competitiveness, regulatory harmonization, and upstream value chain considerations into India's AYUSH export strategy.

Indexed as

AYUSH productsEconomic welfareExport competitivenessPartial equilibrium analysisPolicy implicationsTariff reductionTrade creationTrade diversionTrade intelligence and negotiation advisor (TINA)

Identifiers

PMID42176416
PMCPMC13226236

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.